Skip to main content
Clinical Trials/IRCT20210712051854N1
IRCT20210712051854N1
Recruiting
Phase 3

Triple blind evaluation of the efficacy of oral calcium Hydroxy-apatite on postoperative pain and bone mineral density in patients after pertrochanteric fracture surgery

Daroo Salamat Pharmed0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Daroo Salamat Pharmed
Enrollment
150
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Daroo Salamat Pharmed

Eligibility Criteria

Inclusion Criteria

  • All patients over 65 years referred to Trauma Emergency of Shariati Hospital with pertrochanteric fracture who are candidates for surgery

Exclusion Criteria

  • Patients who are not candidates for surgery due to medical problems with an ASA score of 3 or higher
  • Patients receiving osteoporosis treatments including bisphosphonates, calcium and vitamin D supplements, or hormone therapy prior to surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials